Robert Hart, Forbes Staff

Author's posts

U.K. Launches Covid-19 Trial To Test Mix And Match Vaccine Program

The group will initially give people various mixtures of the AstraZeneca-Oxford vaccine and the Pfizer-BioNTech vaccine.

Next-Gen Vaccine For Covid-19 Mutants Will Be Ready By Fall, AstraZeneca Says

Rapidly spreading variants of Covid-19 are capable of reducing the efficacy of existing vaccines.

Biden, Unlike Trump, Vows To Keep Family Out Of Any Government Decisions And Foreign Policy

The business dealings of Biden’s son, Hunter, came under scrutiny during the presidential campaign.

Russia’s Sputnik V Vaccine Is 92% Effective Against Symptomatic Covid-19, Early Results Show, But There Are No Plans To Bring It To The U.S.

Scientists treated the vaccine skeptically after it was rolled out around the world without completing clinical trials.

Anal Swab Covid Test Won’t Make You Waddle Like A ‘Penguin,’ China Says

Chinese authorities said a viral video of people seemingly struggling to walk after using the newly introduced test is a fake.

Germany Moves To Exclude Seniors From AstraZeneca’s Covid-19 Vaccine

The country’s health agency said there was “insufficient data” on the shot’s effectiveness in people over the age of 65.

AstraZeneca Hits Back At EU Accusation It’s Backtracking On Its Covid-19 Vaccine Contract

The EU accused the company of abandoning its commitments to make a profit elsewhere.

China Deploys Anal Swab Tests To Detect High-Risk Covid-19 Cases

Experts say the test, rolled out before millions are expected to travel for the Lunar New Year, could be more accurate than throat and nose swabs.

Pfizer Will Deliver Covid-19 Vaccines Much Sooner Than Expected

But one syringe supplier said there may not be enough equipment to keep up with the pace of vaccines.

AstraZeneca Battles Supply Chain Issues, Denies Claims Its Covid-19 Vaccine Is Largely Ineffective In Seniors

The EU is demanding AstraZeneca honor its agreement to deliver millions of doses of its vaccine as the company pushes back on German media claiming it has an efficacy of 8% among older people.